Skip to content
ContentLora

    Tip: press / anywhere to search.

    Explainer

    Antibiotic resistance explained: how bacteria beat our drugs

    Antimicrobial resistance (AMR) happens when bacteria, viruses, fungi and parasites stop responding to the medicines meant to kill them, so infections become hard or impossible to treat.[1] About one in six lab-confirmed bacterial infections worldwide were resistant to antibiotics in 2023, and the GRAM study estimates that bacterial AMR directly caused 1.14 million deaths in 2021.[2][3] WHO names misuse and overuse of antibiotics as one of the main drivers.[4]

    Editor reviewedStrict sourcingUpdated Explainer36 claims · 100% primaryInfectious disease, Health and medicine, Life sciences
    Reading level: 1 passage differs; the rest is the same for everyone.

    This page is general information, not medical advice. If you have questions about an infection or about taking antibiotics, talk to a doctor, nurse or pharmacist. For new treatments and the drug pipeline, read how new antibiotics are developed; for the latest data and policy moves, see the antimicrobial resistance tracker.

    Antimicrobial resistance (AMR) is what happens when the germs that cause infections stop responding to the medicines designed to kill them.[1] Antimicrobials include antibiotics, antivirals, antifungals and antiparasitics, but most of the data on this page concern bacteria and antibiotics.[5] WHO says too few new antibiotics are being developed to replace the ones that no longer work.[6]

    How bacteria become resistant

    Resistance is a natural process, but antibiotic use speeds it up.[7] When an antibiotic is used, it kills the bacteria it can kill. The ones that survive keep growing and spreading, and they carry their resistance in their DNA.[8] Bacteria can also pass resistance to other bacteria that never met the drug.[9] It is the germs that become resistant, not the person taking the medicine.[10]

    CDC describes AMR as a naturally occurring process, with increases driven by exposure of germs to antibiotics and antifungals and by the spread of those germs and their resistance mechanisms.[7] Drug exposure acts as selection pressure: resistant organisms survive, multiply and spread, and their resistance traits are encoded in DNA.[8] Resistance mechanisms are proteins specified by genes, and bacteria and fungi can carry genes for many types of resistance.[11] Resistance can also move sideways between organisms. WHO notes that Gram-negative bacteria can pass along genetic material that makes other bacteria drug-resistant.[9]

    Superbugs and WHO’s priority list

    WHO’s 2024 Bacterial Priority Pathogens List ranks 15 families of antibiotic-resistant bacteria as critical, high or medium priority, to steer research on new treatments.[12] The critical tier includes Gram-negative bacteria resistant to last-resort antibiotics and Mycobacterium tuberculosis resistant to rifampicin.[13] The first list came out in 2017, and the 2024 update removed five pathogen–antibiotic combinations and added four.[14]

    E. coli and K. pneumoniae are the leading drug-resistant Gram-negative bacteria in bloodstream infections, which often lead to sepsis, organ failure and death.[15] More than 40% of E. coli and over 55% of K. pneumoniae are now resistant globally to third-generation cephalosporins, the usual first-choice treatment.[16]

    Other examples from WHO:

    • Gonorrhoea. Ciprofloxacin resistance is very high, at 75%, and resistance to ceftriaxone is rising in some regions.[17]
    • Tuberculosis. An estimated 3.2% of people with a first episode of TB in 2024 had drug-resistant TB, and 16% of those treated before.[18]
    • Fungi. WHO flags multidrug-resistant Candidozyma auris and azole-resistant Aspergillus.[19]

    How big the problem is

    WHO’s 2025 surveillance report, based on data from over 100 countries, found that about one in six lab-confirmed bacterial infections in 2023 were resistant.[20][2] Resistance rose in over 40% of the pathogen–antibiotic combinations WHO monitored between 2018 and 2023.[21] It was highest in WHO’s South-East Asia and Eastern Mediterranean regions, where 1 in 3 reported infections were resistant.[22]

    The best-known death estimates come from the Global Research on Antimicrobial Resistance (GRAM) study, published in The Lancet in 2024:

    Measure (GRAM estimates)Deaths directly caused by AMRDeaths associated with AMR
    20191.27 million4.95 million
    20211.14 million4.71 million
    2050 (forecast)1.91 million8.22 million
    2025–2050 total (forecast)more than 39 million169 million

    Sources for the table: 2019,[23] 2021,[3] 2050[24] and the 2025–2050 total.[25]

    “Directly caused” means the resistant infection was the cause of death; “associated” means it was a contributing factor.[26] The 2021 figure was lower than 2019 because there were fewer non-COVID lower respiratory infections, which the authors say social distancing and other disease control measures likely reduced.[23] The burden is shifting toward older people: deaths among children under five fell by about half between 1990 and 2021, while deaths among people aged 70 and over rose by more than 80%.[27] The authors say data gaps in some low- and middle-income countries weaken parts of the estimates.[28] The forecasts are modelled projections based on current trends, not counts.[24]

    In the United States, CDC’s 2026 threats report estimates more than 9.3 million drug-resistant infections and more than 39,000 deaths a year.[29] WHO also cites projections that treating resistant bacterial infections could cost US$412 billion a year up to 2035.[30]

    What drives resistance

    WHO names the misuse and overuse of antibiotics, such as taking them when they are not needed or taking the wrong type, as one of the main drivers.[4] Its wider list of key factors includes:[31]

    • inappropriate use of antibiotics;
    • poor access to clean water, sanitation and hygiene;
    • weak infection prevention and control in homes, health facilities and farms;
    • limited access to vaccines, diagnostics and medicines.

    In 2022, WHO’s “Access” antibiotics, the first-choice group for most common infections, made up only about 53% of human use, against a target of at least 70% by 2030.[32] “Watch” antibiotics, which carry a higher risk of resistance, made up roughly 45%.[32]

    What is being done

    In September 2024 the UN General Assembly adopted a political declaration with a target to cut the estimated 4.95 million annual deaths associated with bacterial AMR by 10% by 2030.[33] In May 2026 the World Health Assembly adopted an updated Global Action Plan on AMR for 2026–2036.[34] Delegates stressed prevention first, including infection control, clean water and sanitation, and vaccination.[35] In GRAM’s scenarios, better infection care and access to antibiotics could avert 92 million deaths between 2025 and 2050.[36]

    How new drugs are found and paid for is covered in how new antibiotics are developed. We have not covered antiviral, HIV or malaria drug resistance in depth here. Related reading: meningitis explained for one of the infections where resistance is a concern.

    Next in the crash course

    More in Infectious disease

    Questions readers ask

    What is antimicrobial resistance?

    WHO defines it as bacteria, viruses, fungi and parasites no longer responding to antimicrobial medicines, which makes infections difficult or impossible to treat. Antimicrobials include antibiotics, antivirals, antifungals and antiparasitics.[1][5]

    Does my body become resistant to antibiotics?

    No. It is the germs that change. CDC describes resistance as germs developing the ability to defeat the drugs, with resistant germs surviving, multiplying and spreading.[10][8]

    How many people die from antibiotic resistance?

    The GRAM study estimated that bacterial AMR directly caused 1.14 million deaths in 2021 and was associated with 4.71 million. It forecasts 1.91 million direct deaths a year by 2050 if current trends continue.[3][24]

    Which drug-resistant bacteria are the most dangerous?

    WHO's 2024 priority list ranks 15 families of resistant bacteria. The critical tier includes Gram-negative bacteria resistant to last-resort antibiotics and rifampicin-resistant tuberculosis.[12][13]

    What causes antibiotic resistance to spread?

    WHO lists inappropriate antibiotic use, poor water, sanitation and hygiene, weak infection prevention and control, and limited access to vaccines, diagnostics and medicines among the key factors.[31]

    Is resistance getting worse?

    WHO found that between 2018 and 2023 resistance rose in over 40% of the pathogen–antibiotic combinations it monitors, by 5–15% a year on average.[21]

    Sources

    · 36 claims from 4 publishers

    Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.

    1. [1]

      WHO defines antimicrobial resistance (AMR) as bacteria, viruses, fungi and parasites no longer responding to antimicrobial medicines, which makes infections difficult or impossible to treat. confirmedas of 2026-11-07

    2. [2]

      About one in six laboratory-confirmed bacterial infections worldwide in 2023 were resistant to antibiotic treatment, according to WHO's Global antibiotic resistance surveillance report 2025. confirmedas of 2025-10-13

    3. [3]

      The GRAM study in The Lancet (2024) estimated that bacterial AMR directly caused 1.14 million deaths in 2021 and was associated with 4.71 million deaths. confirmedas of 2024-09-16

    4. [4]

      WHO says misuse and overuse of antibiotics, such as taking them when they are not needed or taking the wrong type, remains one of the main drivers of AMR. confirmedas of 2026-11-07

    5. [5]

      Antimicrobials include antibiotics, antivirals, antifungals and antiparasitics, used to prevent and treat infections in people, animals and plants. confirmedas of 2026-11-07

    6. [6]

      WHO says too few new antibiotics are being developed to replace those that no longer work. confirmedas of 2026-11-07

    7. [7]

      CDC describes antimicrobial resistance as a naturally occurring process whose increase is driven by germs being exposed to antibiotics and antifungals and by the spread of those germs and their resistance mechanisms. confirmedas of 2026-11-07

    8. [8]

      According to CDC, antibiotic and antifungal use pressures bacteria and fungi to adapt; the resistant germs survive, multiply and spread, carrying resistance traits in their DNA. confirmedas of 2026-11-07

    9. [9]

      Resistant bacteria can pass resistance to other bacteria, including ones never exposed to the drug; WHO says Gram-negative bacteria can pass along genetic material that makes other bacteria drug-resistant. confirmedas of 2026-11-07

    10. [10]

      CDC says antimicrobial resistance happens when germs such as bacteria and fungi develop the ability to defeat the drugs designed to kill them, so the germs keep growing. confirmedas of 2026-11-07

    11. [11]

      Germs develop defences against drugs called resistance mechanisms, and the genes for many types of resistance can be carried in bacterial and fungal DNA. confirmedas of 2026-11-07

    12. [12]

      WHO's 2024 Bacterial Priority Pathogens List covers 15 families of antibiotic-resistant bacteria grouped into critical, high and medium priority to guide research and development. confirmedas of 2024-05-17

    13. [13]

      The critical tier of the 2024 list includes Gram-negative bacteria resistant to last-resort antibiotics and rifampicin-resistant Mycobacterium tuberculosis. confirmedas of 2024-05-17

    14. [14]

      WHO released its first Bacterial Priority Pathogens List in 2017; the 2024 update removed five pathogen–antibiotic combinations and added four. confirmedas of 2024-05-17

    15. [15]

      WHO says E. coli and K. pneumoniae are the leading drug-resistant Gram-negative bacteria in bloodstream infections, which often lead to sepsis, organ failure and death. confirmedas of 2026-11-07

    16. [16]

      More than 40% of E. coli and over 55% of K. pneumoniae are now resistant globally to third-generation cephalosporins, the first-choice treatment for these infections, and resistance exceeds 70% in WHO's African Region. confirmedas of 2025-10-13

    17. [17]

      WHO reports very high (75%) ciprofloxacin resistance in gonorrhoea, while resistance to ceftriaxone is still low globally but rising in some regions. confirmedas of 2026-11-07

    18. [18]

      WHO estimates that 3.2% of people with a first episode of tuberculosis in 2024 had drug-resistant TB, rising to 16% among people previously treated for TB. confirmedas of 2026-11-07

    19. [19]

      WHO flags multidrug-resistant Candidozyma auris (formerly Candida auris) and azole-resistant Aspergillus as growing fungal resistance concerns. confirmedas of 2026-11-07

    20. [20]

      The 2025 WHO surveillance report drew on data from over 100 countries and, for the first time, estimated resistance across 22 antibiotics and 8 common bacterial pathogens. confirmedas of 2025-10-13

    21. [21]

      Between 2018 and 2023, antibiotic resistance rose in over 40% of the pathogen–antibiotic combinations WHO monitored, with an average annual increase of 5–15%. confirmedas of 2025-10-13

    22. [22]

      WHO estimates resistance is highest in its South-East Asia and Eastern Mediterranean regions, where 1 in 3 reported infections were resistant, compared with 1 in 5 in the African Region. confirmedas of 2025-10-13

    23. [23]

      GRAM estimates put 2019 at 1.27 million deaths directly due to AMR and 4.95 million associated deaths; 2021 was lower because of fewer non-COVID lower respiratory infections, which the authors say were likely reduced by social distancing and other disease control measures. confirmedas of 2024-09-16

    24. [24]

      GRAM forecasts 1.91 million deaths directly due to AMR in 2050 and 8.22 million associated deaths, if current trends continue. confirmedas of 2024-09-16· forecast

    25. [25]

      GRAM estimates that between 2025 and 2050 AMR will directly cause more than 39 million deaths and be associated with 169 million. confirmedas of 2024-09-16· forecast

    26. [26]

      GRAM counts deaths in two ways, deaths where a resistant infection was the direct cause and a broader count where it was a contributing factor. confirmedas of 2024-09-16

    27. [27]

      Between 1990 and 2021, AMR deaths among children under five fell by about 50%, while deaths among people aged 70 and older rose by more than 80%, according to GRAM. confirmedas of 2024-09-16

    28. [28]

      The GRAM authors note that missing data for some low- and middle-income countries and limited reporting before 2000 weaken parts of the estimates. confirmedas of 2024-09-16

    29. [29]

      CDC's 2026 Antimicrobial Resistance Threats Report estimates more than 9.3 million drug-resistant infections and more than 39,000 resulting deaths in the United States each year. confirmedas of 2026-11-07

    30. [30]

      WHO cites projections that, at the current level of action, treating resistant bacterial infections will cost US$412 billion a year up to 2035, with further productivity losses of US$443 billion a year. confirmedas of 2026-11-07· forecast

    31. [31]

      WHO lists the key factors behind the emergence and spread of AMR as inappropriate antibiotic use, poor access to clean water, sanitation and hygiene, weak infection prevention and control, limited access to vaccines, diagnostics and medicines, and weak awareness and enforcement of legislation. confirmedas of 2026-11-07

    32. [32]

      In 2022, WHO "Access" antibiotics, the first-choice group for most common infections, made up about 53% of global human antibiotic use, short of the target of at least 70% by 2030; higher-resistance-risk "Watch" antibiotics made up roughly 45%. confirmedas of 2026-11-07

    33. [33]

      The political declaration on AMR adopted at the UN General Assembly in September 2024 commits countries to reduce the estimated 4.95 million annual deaths associated with bacterial AMR by 10% by 2030. confirmedas of 2024-09-26

    34. [34]

      On 23 May 2026 member states at the 79th World Health Assembly adopted the updated Global Action Plan on Antimicrobial Resistance for 2026–2036, which builds on the original plan adopted in 2015. confirmedas of 2026-05-25

    35. [35]

      During the 2026 Assembly, delegates stressed prevention-first measures including infection prevention and control, water, sanitation and hygiene, vaccination and biosecurity. confirmedas of 2026-05-25

    36. [36]

      In GRAM's scenarios, better infection care and access to antibiotics could avert 92 million deaths between 2025 and 2050, and new antibiotics against Gram-negative bacteria could avert 11.08 million AMR-attributable deaths. confirmedas of 2024-09-16· forecast

    Revision history (1)
    1. Page created.

    Created Nov 7, 2026. Last reviewed by an editor on Nov 8, 2026. Next scheduled review: Apr 7, 2027.

    Cite this page

    "Antibiotic resistance explained: how bacteria beat our drugs." ContentLora, updated Nov 7, 2026. https://contentlora.com/explain/antibiotic-resistance-explained

    Spotted an error? Suggest a correction or emailcorrections@contentlora.com.